Rockwell Medical Inc (RMTI)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$7.990.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · RMTI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 69.4 | 69.3 | 101.5 | 83.6 | 72.8 | 61.9 | 62.2 | 61.3 | 63.4 | 57.3 | 53.3 | 55.4 | 54.2 | 52.4 | 49.8 | 49.0 |
| Cost of Revenues | 57.1 | 57.6 | 84.0 | 74.9 | 68.7 | 64.4 | 59.5 | 58.5 | 65.0 | — | — | — | — | — | — | — |
| Gross Profit | 12.3 | 11.7 | 17.5 | 8.7 | 4.1 | (2.4) | 2.7 | 2.8 | (1.6) | 3.7 | 6.8 | 8.9 | 8.5 | 6.7 | 6.7 | 5.6 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | — | — | — | — | — | — | — | 23.1 | 23.3 | 21.1 | 19.1 | 18.3 | 14.3 | 12.7 | 9.5 |
| R&D Expenses | — | — | 0.0 | 1.1 | — | — | — | — | 5.6 | 6.3 | 5.8 | 5.0 | 7.8 | 39.4 | 48.3 | 17.8 |
| Operating Income | (4.5) | (4.7) | 0.6 | (6.7) | (16.8) | (30.3) | (28.4) | (34.5) | (32.4) | (25.9) | (20.2) | (15.1) | (17.6) | (47.1) | (54.3) | (21.7) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 1.1 | 1.3 | 2.3 | 1.9 | 2.4 | 1.9 | — | — | — | — | — | — | — | — | — |
| Interest & Investment Income | — | — | — | 0.2 | 0.0 | 0.0 | 0.2 | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | 2.1 | 1.9 | 2.3 | 1.6 | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (5.3) | (0.5) | (8.4) | — | — | — | — | — | (25.9) | (19.4) | (14.4) | (21.3) | (48.8) | (54.0) | (21.4) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | (5.1) | (5.3) | (0.5) | (8.4) | (18.7) | (32.7) | (30.9) | (34.1) | (32.1) | (25.9) | (19.8) | (14.4) | (21.3) | (48.8) | (54.0) | (21.4) |
| Per Share | ||||||||||||||||
| Basic EPS | (1.28) | (0.15) | (0.03) | (0.37) | (1.31) | (3.83) | (0.41) | — | — | (0.51) | (0.39) | — | — | — | — | — |
| Diluted EPS | (1.28) | (0.15) | (0.03) | (0.37) | (1.31) | (3.83) | (0.41) | — | — | (0.51) | (0.39) | — | — | — | — | — |
| Revenue per Share | 17.53 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 4.0 | 36.0 | 31.1 | 23.3 | 14.3 | 8.5 | 75.6 | — | — | 51.1 | 50.7 | 50.1 | 41.4 | 32.9 | 20.4 | — |
| Diluted Weighted Avg Shares | 4.0 | 36.0 | 31.1 | 23.3 | 14.3 | 8.5 | 75.6 | — | — | 51.1 | 50.7 | 50.1 | 41.4 | 32.9 | 20.4 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (2.5) | 2.8 | (5.2) | (16.2) | (29.7) | (27.6) | (33.7) | (31.8) | (25.4) | (19.4) | (14.3) | (16.6) | (46.1) | (53.2) | (20.5) |
| EBIT | (4.5) | (4.7) | 0.6 | (6.7) | (16.8) | (30.3) | (28.4) | (34.5) | (32.4) | (25.9) | (20.2) | (15.1) | (17.6) | (47.1) | (54.3) | (21.7) |
| Effective Tax Rate | — | — | — | 0.0% | — | — | — | — | — | 0.0% | -2.1% | 0.0% | 0.0% | 0.0% | 0.0% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.